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Gotoh, Jun, Tang-Yong Kuang, Yasuaki Nakao,
David M. Cohen, Peter Melzer, Yoshiaki Itoh, Hazel
Pak, Karen Pettigrew, and Louis Sokoloff. Regional
differences in mechanisms of cerebral circulatory response to
neuronal activation. Am J Physiol Heart Circ Physiol 280:
H821–H829, 2001.—Vibrissal stimulation raises cerebral
blood ﬂow (CBF) in the ipsilateral spinal and principal sen-
sory trigeminal nuclei and contralateral ventroposteromedial
(VPM) thalamic nucleus and barrel cortex. To investigate
possible roles of adenosine and nitric oxide (NO) in these
increases, local CBF was determined during unilateral
vibrissal stimulation in unanesthetized rats after adenosine
receptor blockade with caffeine or NO synthase inhibition
with N
G-nitro-L-arginine methyl ester (L-NAME) or 7-nitroi-
ndazole (7-NI). Caffeine lowered baseline CBF in all struc-
tures but reduced the percent increase during stimulation
only in the two trigeminal nuclei. L-NAME and 7-NI lowered
baseline CBF but reduced the percent increase during stim-
ulation only in the higher stations of this sensory pathway,
i.e., L-NAME in the VPM nucleus and 7-NI in both the VPM
nucleus and barrel cortex. Combinations of caffeine with
7-NI or L-NAME did not have additive effects, and none alone
or in combination completely eliminated functional activa-
tion of CBF. These results suggest that caffeine-sensitive and
NO-dependent mechanisms are involved but with different
regional distributions, and neither fully accounts for the
functional activation of CBF.
adenosine; nitric oxide; caffeine; 7-nitroindazole; N
G-nitro-L-
arginine
NUMEROUS STUDIES HAVE ESTABLISHED that neuronal func-
tional activation is associated with increases in both
cerebral energy metabolism and blood ﬂow (CBF) in
components of the activated neural pathway (8, 18,
30–32). The increases in energy metabolism evoked by
functional activation have been shown to be propor-
tional to the increases in spike frequency in the affer-
ent inputs to the activated areas (13, 32) and to be due
mainly to activation of Na
1-K
1-ATPase activity (21,
32). The mechanisms mediating the increases in CBF
during functional activation remain, however, largely
undeﬁned. A popular hypothesis proposed by Roy and
Sherrington (27) was that CBF is intrinsically regu-
lated by products of energy metabolism to meet the
altered metabolic demands associated with functional
activity. This hypothesis received support from subse-
quent ﬁndings that CBF is raised by increased CO2
tension, lowered pH, and decreased oxygen tension, all
expected consequences of increased tissue metabolism,
and reduced by changes in these chemical factors in the
opposite direction, to be expected with decreased me-
tabolism (14). Since then, many other endogenous
agents that affect cerebral blood vessels, e.g., nitric
oxide (NO), adenosine, adenine nucleotides, K
1, pros-
taglandins, vasoactive intestinal peptide, etc., have
been identiﬁed and considered as possible candidates,
but not one of them, alone or in combination with
others, has yet been proven to account fully or even to
be essential for the enhancement of CBF by neuronal
activation.
Inhibition of cerebral glucose utilization by hypogly-
cemia or pharmacological doses of 2-deoxyglucose (2-
DG) has been found to result in marked increases in
CBF (3, 10). Inasmuch as these conditions depress
cerebral energy metabolism, the increases in CBF can-
not be ascribed to vasodilator products of glucose
and/or oxygen metabolism. Recently, Horinaka et al.
(11) found that caffeine dose dependently attenuates to
the point of complete elimination the elevation of CBF
in hypoglycemia. Caffeine is a nonselective antagonist
of adenosine receptors, and adenosine has vasodilator
properties that have led to its consideration as a po-
tential mediator of the adjustment of CBF to functional
and metabolic activities (25, 28, 37). The present stud-
ies were undertaken to determine whether caffeine
might also inhibit the enhancement of CBF by func-
tional neuronal activation. A number of studies, all
carried out in anesthetized animals and most often
with laser-Doppler ﬂowmetry applied only to the cere-
bral cortex, have implicated NO in the functional acti-
vation of CBF (2, 4, 7, 12, 19). In contrast, studies with
the nonspeciﬁc NO synthase inhibitor, N
G-nitro-L-argi-
nine methyl ester (L-NAME), in which CBF was quan-
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failed to support such a role for NO (1, 33, 36). To our
knowledge, the effects of the speciﬁc inhibitor of neu-
ronal NO synthase, 7-nitroindazole (7-NI), have never
been examined in unanesthetized animals. We there-
fore also compared in this study the effects of caffeine,
L-NAME, and 7-NI, each administered alone, and com-
binations of caffeine with each of the NO synthase
inhibitors. The studies were carried out in unanesthe-
tized rats, functional activation was elicited by vibris-
sal stimulation, and absolute rates of CBF were quan-
titatively determined in four stations of the whisker-
to-barrel cortex pathway.
MATERIALS AND METHODS
Chemicals
2-[1-
14C]DG (2-[
14C]DG; sp. act. 51 mCi/mmol) and 4-[N-
methyl-
14C]iodoantipyrine ([
14C]IAP; sp. act. 54 mCi/mmol)
were obtained from NEN (Boston, MA). Caffeine, L-NAME,
7-NI, and DMSO were obtained from Sigma (St. Louis, MO).
Animals
All procedures performed on animals were in strict accor-
dance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and were approved by
the local Animal Care and Use Committee.
Normal, adult, male Sprague-Dawley rats (290–410 g)
were obtained from Charles River Laboratories (Wilmington,
MA). They were maintained on a 12:12-h light-dark cycle
with humidity and temperature controlled at normal levels
and were allowed food and water ad libitum until deprived of
food but not water ;16 h before the experiment. On the day
of the experiment, the rats were anesthetized with halothane
(5% for induction, 1.0–1.5% for maintenance) in 70% N2O-
30% O2, and polyethylene catheters (PE-50; Clay-Adams,
Parsippany, NJ) were inserted in both femoral arteries and
one femoral vein. Also, the vibrissae on the right side of the
face were cut close to the skin to minimize spurious stimu-
lation on the unstimulated control side. Lidocaine ointment
(5%) was applied to the surgical wounds after closure. Loose-
ﬁtting plaster casts were then applied to the lower torso to
prevent locomotion but to allow free movement of the head,
forelimbs, and upper torso. Body temperature was main-
tained at 37°C throughout the experiment by a servo-con-
trolled infrared heating lamp connected to a rectal ther-
mistor.
After at least 3 h for recovery from surgery and anesthesia,
vibrissal stimulation and measurement of either local CBF or
local cerebral glucose utilization (lCMRGlc) were initiated.
The vibrissae on the left side of the face were stroked forward
and backward continuously with a small paint brush at a
rate of 2–4 strokes/s throughout the 1-min period of mea-
surement of local CBF or the 45-min period of measurement
of lCMRGlc.
Local CBF was determined during unilateral vibrissal
stimulation in eight groups of rats. Groups 1, 2, and 3 were
injected intravenously with saline, 20 mg/kg of caffeine, or 40
mg/kg of caffeine, respectively, 15 min before initiation of
whisker stroking and measurement of CBF. Group 4 was
injected intravenously with 30 mg/kg of L-NAME 30 min
before vibrissal stimulation and CBF measurement. Groups
5 and 6 were injected intraperitoneally with either DMSO
alone or 30 mg/kg of 7-NI dissolved in DMSO, respectively, 30
min before onset of whisker stroking and CBF measurement.
Groups 7 and 8 were injected with a combination of 20 mg/kg
of caffeine and either L-NAME or 7-NI, respectively, with
each drug injected as above. In two additional groups of rats,
lCMRGlc was measured in the four stations of the whisker-
to-barrel cortex pathway during similar vibrissal stimula-
tion; one was a saline-treated control group, and the other
was injected intravenously with 40 mg/kg of caffeine 15 min
before onset of vibrissal stimulation and measurement of
lCMRGlc. Because energy metabolism is probably more di-
rectly linked to functional activity, lCMRGlc was measured to
assess whether caffeine effects on the CBF responses to
functional activation were secondary to alterations in the
intensity of neuronal functional activation or directly on
mechanisms of regulation of CBF during activation.
Physiological Variables
Mean arterial blood pressure (MABP) was measured with
a Digi-Med Blood Pressure Analyzer (Micro-Med, Louisville,
KY). Hematocrit was determined in arterial blood samples
centrifuged in a Microfuge B (Beckman Instruments, Fuller-
ton, CA). Arterial blood PO2,P CO2, and pH were measured
with a Corning pH/blood gas analyzer (model 288; Corning
Medical, Medﬁeld, MA). Arterial plasma glucose content was
measured in a Beckman Glucose Analyzer 2 (Beckman In-
struments).
Because caffeine stimulated respiration and lowered arte-
rial PCO2, caffeine-treated rats were placed in transparent
plastic bags that were intermittently ventilated with 5% CO2
in humidiﬁed room air at a rate of 1–5 l/min as needed to
maintain arterial PCO2 within normal limits. The saline-
treated control rats were treated similarly, except that the
bags were ventilated with humidiﬁed room air. Arterial PCO2,
PO2, pH, and MABP were measured before drug or saline
administration and again just before measurements of CBF
or lCMRGlc.
Measurement of Local CBF
Local CBF was determined by the autoradiographic
[
14C]IAP method as previously described (29), except that the
[
14C]IAP (40 mCi in 0.8 ml of physiological saline) was con-
tinuously infused via the femoral venous catheter by a com-
puter-driven infusion pump (model 2400–003; Harvard Ap-
paratus, South Natick, MA) programmed to produce a
constantly rising arterial [
14C]IAP concentration. Timed ar-
terial samples were collected on weighed ﬁlter paper discs
throughout the infusion period and later were assayed for
[
14C]IAP concentration by liquid scintillation counting as
previously described (29). At a precisely recorded time ;1
min after onset of the infusion, the rat was decapitated, and
the brain was removed, frozen in isopentane maintained at
240 to 250°C with dry ice, and cut into 20-mm sections in a
cryostat at 222°C. The frozen brain sections were mounted
on glass coverslips, immediately dried on a hot plate at
;60°C, and autoradiographed together with calibrated
[
14C]methylmethacrylate standards on Kodak EMC-1 X-ray
ﬁlm (Kodak, Rochester, NY). Local tissue concentrations of
[
14C]IAP were determined by densitometric analysis of the
autoradiograms, and rates of local CBF were calculated from
the local tissue concentrations and the time course of the
arterial [
14C]IAP concentration by means of the operational
equation of the method (29) and the computer program de-
veloped by G. Mies (Max Planck Institut fu ¨r Neurologische
Forschung, Ko ¨ln, Germany) for use with the NIH Image
program (W. Rasband, National Institute of Mental Health,
Bethesda, MD) and Macintosh computer.
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lCMRGlc was measured bilaterally in the spinal and prin-
cipal trigeminal nuclei, ventroposteromedial (VPM) thalamic
nucleus, and barrel region of the sensory cortex by the quan-
titative autoradiographic 2-[
14C]DG method (34) during uni-
lateral vibrissal stimulation. Vibrissal stimulation was be-
gun simultaneously with the intravenous injection of a pulse
of 125 mCi/kg of 2-[
14C]DG that initiated the period of mea-
surement of lCMRGlc. Timed arterial blood samples were
then drawn and centrifuged, and the time courses of the
plasma glucose and 2-[
14C]DG concentrations over the ;45-
min experimental period were determined as previously de-
scribed (34). At the end of the experimental period, the rats
were decapitated, and their brains were frozen, sectioned,
and autoradiographed as described above. Local tissue con-
centrations of
14C in the four stations of the whisker-to-
barrel cortex pathway were determined by the same comput-
erized image-processing system used for the determination of
local CBF, and lCMRGlc was calculated from the local tissue
14C concentrations and the time courses of the arterial
plasma glucose and 2-[
14C]DG concentrations according to
the operational equation of the method (34).
Statistics
In all animals, local CBF or lCMRGlc was determined
bilaterally in the four stations of the whisker-to-barrel cortex
pathway. Local CBF was also determined bilaterally in 18
structures outside the pathway. Data are expressed as
means 6 SE for the number of animals indicated in Figs. 1–5
and Table 1. For each structure, a side-to-side comparison
was made with a paired t-test on the absolute values of CBF
or lCMRGlc. Statistical analyses of the percent difference
between the two sides were made on logarithmically trans-
formed percentages. Homogeneity of groups with respect to
side-to-side percentage differences for each structure was
ﬁrst analyzed by a one-way ANOVA followed by pair-wise
t-tests between groups. Statistical signiﬁcance of differences
between groups in the absolute values of local CBF, lCMRGlc,
or physiological variables was determined by Student’s t-test
or one-way ANOVA followed by Dunnett’s t-test when mul-
tiple groups were compared against a single group.
RESULTS
Effects of Caffeine Administration
Effects on behavior and physiological variables. Caf-
feine administration evoked hyperventilation and be-
havioral changes, e.g., snifﬁng, intense grooming, head
bobbing, chewing, and paw pushing, that persisted
throughout the experimental period. These effects
were more striking with the larger dose of caffeine.
Effects of hyperventilation on arterial PCO2 were con-
trolled by intermittent addition of 5% CO2 to the in-
spired air as needed, but arterial PO2 rose signiﬁcantly
and pH tended to fall after caffeine administration
(Table 1).
Effects of caffeine on baseline CBF and functional
activation of CBF. In both control and caffeine-treated
groups, none of the 18 structures outside the whisker-
to-barrel cortex pathway that were examined exhibited
statistically signiﬁcant side-to-side differences in CBF
(Fig. 1). Both doses of caffeine (20 and 40 mg/kg),
however, produced dose-dependent, statistically signif-
icant (P , 0.05 or ,0.01) reductions in CBF in most of
these structures (Fig. 1). Caffeine also tended to reduce
CBF in the unstimulated side of the four structures of
the whisker-to-barrel cortex pathway, but these reduc-
tions reached statistical signiﬁcance (P , 0.05) only
with the 40 mg/kg dose in the spinal trigeminal nu-
cleus, VPM nucleus, and barrel cortex (Fig. 2).
In the saline-treated controls, unilateral vibrissal
stimulation markedly raised CBF in the ipsilateral
spinal trigeminal (168%) and principal sensory tri-
geminal (160%) nuclei and the contralateral VPM nu-
cleus (129%) and barrel cortex (151%) above the levels
in the homologous structures of the unstimulated side
(P , 0.005; Fig. 2). Both doses of caffeine reduced the
percent increase in CBF due to stimulation to about
half in the spinal (P , 0.01) and principal trigeminal
(P , 0.04) nuclei (Fig. 2). Caffeine also tended to dose
dependently lower the percent increase in CBF due to
stimulation in the VPM thalamic nucleus and to en-
hance the percent increase in the barrel cortex, but
these effects failed to achieve statistical signiﬁcance
(Fig. 2).
Effects of caffeine on the functional activation of local
glucose utilization. Energy metabolism is probably
more directly coupled to neuronal functional activity
than blood ﬂow. Therefore, to assess whether the ef-
fects of caffeine on the percentage of the changes in
CBF evoked by vibrissal stimulation were secondary to
alterations in metabolism or intensity of neuronal ac-
tivation or were due to an action on the mechanisms of
Table 1. Physiological variables immediately before measurement of cerebral blood ﬂow
Treatment n
Mean Arterial
Blood Pressure,
mmHg
Arterial PCO2,
mmHg
Arterial PO2,
mmHg Arterial pH
Saline 7 112613 5 60.5 8561 7.4560.01
Caffeine (20 mg/kg) 10 114633 7 62 11464† 7.4060.01*
Caffeine (40 mg/kg) 8 115643 6 61 10964† 7.4260.01
Saline1L-NAME (30 mg/kg) 5 13162† 36619 2 61 7.4160.004
Caffeine (20 mg/kg)1L-NAME (30 mg/kg) 7 13562† 3861 10763* 7.3860.01†
Saline1DMSO 6 122623 6 619 2 63 7.4460.01
Saline17-NI in DMSO (30 mg/kg) 6 119624 0 619 7 66 7.4060.01
Caffeine (20 mg/kg)17-NI in DMSO (30 mg/kg) 8 122633 9 61 10768† 7.3860.02†
Values are means 6 SE obtained immediately before measurement of cerebral blood ﬂow (CBF) in no. of animals (n) indicated. L-NAME,
N
G-nitro-L-arginine methyl ester; 7-NI, 7-nitroindazole. All treatments were administered intravenously except for DMSO, which was
administered intraperitoneally. *P , 0.05 and †P , 0.01 compared with saline-treated controls.
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effects of caffeine on the changes in lCMRGlc evoked by
vibrissal stimulation. Unilateral vibrissal stimulation
markedly raised lCMRGlc in the stimulated sides of all
four stations of the pathway, and these increases were
not reduced by the caffeine treatment (Fig. 3). In fact,
in the barrel cortex, caffeine statistically signiﬁcantly
(P , 0.05) enhanced the percentage of increase in
lCMRGlc due to stimulation (Fig. 3).
Effects of Inhibitors of NO Synthase on CBF
Response to Functional Activation
L-NAME is a nonspeciﬁc inhibitor of endothelial, neu-
ronal, and inducible NO synthase activities, whereas
7-NI speciﬁcally inhibits only the neuronal isoform.
Because of uncertainty about which of these isoforms,
if any, was involved in the CBF response to functional
activation, we examined the effects of both inhibitors.
Effects of 7-NI. Because 7-NI had to be dissolved in
DMSO and administered intraperitoneally, it was also
necessary to examine the effects of intraperitoneal
DMSO alone. Compared with values obtained in the
saline-treated controls, DMSO had no statistically sig-
niﬁcant effects on any of the physiological variables
(Table 1), baseline CBF, or percentage of increases in
CBF evoked by vibrissal stimulation (Fig. 4). 7-NI
lowered baseline CBF statistically signiﬁcantly (P ,
0.05 by Dunnett’s t-test for multiple comparisons) in
the spinal and principal trigeminal nuclei, but compa-
rable reductions in the VPM nucleus and barrel cortex
were statistically signiﬁcant only by Student’s t-test
(P , 0.04) and not the Dunnett’s test (Fig. 4). Almost
exactly opposite to the effects of caffeine (i.e., statisti-
cally signiﬁcantly reduced percentage of increases in
CBF due to vibrissal stimulation in the two trigeminal
nuclei and not in the VPM nucleus and barrel cortex),
7-NI had no effects in the two brain stem nuclei but
signiﬁcantly diminished the responses in the VPM
nucleus (P ' 0.05) and barrel cortex (P , 0.04; Fig. 4).
Effects of L-NAME. Intravenous administration of
L-NAME (30 mg/kg) had no effects on arterial PCO2 and
PO2 but raised MABP from 113 6 6 (mean 6 SD) before
to 131 6 5 mmHg 30 min after its injection (P , 0.01).
Despite the higher MABP during the measurement of
CBF (Table 1), L-NAME treatment lowered baseline
CBF on the unstimulated side in all four stations of the
whisker-to-cortex pathway by ;25–41% below the lev-
els in the saline-treated controls (Fig. 4). The reduc-
tions in baseline CBF cannot be attributed to lowered
energy metabolism because systemic administration of
L-NAME has been found to have no effects on lCMRGlc
in a variety of cerebral structures in unanesthetized
rats (35). The increases in MABP and cerebral vascular
resistance and reductions in baseline CBF produced by
Fig. 1. Effects of caffeine on cerebral blood ﬂow (CBF)
during stimulation of vibrissae on the left side of the
face in structures outside the whisker-to-barrel cortex
pathway. Bar heights and error bars represent mean
CBF 6 SE for no. of animals indicated in bars. The
%values represent the means of the individual percent-
age of differences between left and right sides for that
structure in all of the animals. None of these structures
exhibited a statistically signiﬁcant difference between
stimulated and unstimulated sides. Caff 20 and caff 40,
doses of 20 and 40 mg/kg caffeine, respectively. *P ,
0.05 and **P , 0.01, statistically signiﬁcant different
CBF in caffeine-treated animals compared with saline-
treated control group (determined by Dunnett’s t-test
for multiple comparisons with a single control group).
H824 ADJUSTMENT OF CEREBRAL BLOOD FLOW TO NEURONAL ACTIVITYL-NAME therefore indicate that it effectively inhibited
a tonic vasodilator inﬂuence of NO in both the systemic
and cerebral circulatory beds. Despite its effects on
baseline CBF, however, L-NAME did not statistically
signiﬁcantly alter the percent enhancement of CBF
evoked by vibrissal stimulation in any of the stations of
the pathway, except in the VPM thalamic nucleus (P ,
0.05; Fig. 4).
Effects of Combinations of Caffeine with Either
L-NAME or 7-NI
Although caffeine, L-NAME, and 7-NI reduced the
percent enhancement of CBF due to vibrissal stimula-
tion in selected structures, they did not fully eliminate
the functional activation of CBF in any of them. Be-
cause of the possibility of multiple mechanisms of reg-
Fig. 2. Effects of 20 and 40 mg/kg in-
travenous doses of caffeine on baseline
blood ﬂow and increases in blood ﬂow
evoked by functional activation in four
stations of the whisker-to-barrel cortex
pathway. A: spinal trigeminal nucleus;
B: principal sensory trigeminal nucle-
us; C: ventral posteromedial (VPM)
thalamic nucleus; D: barrel ﬁeld of sen-
sory cortex. Bar heights and error bars
represent means 6 SE of no. of ani-
mals indicated. See Statistics for sta-
tistical tests. All side-to-side differ-
ences were statistically signiﬁcant
(P , 0.02); the %values shown are the
percentage of differences between the
two sides. Also, the 40 mg/kg dose of
caffeine statistically signiﬁcantly (P ,
0.05) reduced the CBF values in the
spinal trigeminal nucleus, VPM nu-
cleus, and barrel cortex on the un-
stimulated side below the values in the
saline-treated control rats. *P , 0.05,
statistically signiﬁcant reduction in
percent enhancement of blood ﬂow due
to vibrissal stimulation compared with
those seen in saline-treated control
rats.
Fig. 3. Effects of caffeine (40 mg/kg) on
activation of local cerebral glucose uti-
lization by unilateral vibrissal stimu-
lation in four stations of whisker-to-
barrel cortex sensory pathway. A:
spinal trigeminal nucleus; B: principal
sensory trigeminal nucleus; C: ventral
posteromedial thalamic nucleus; D:
barrel ﬁeld of sensory cortex. Bar
heights and error bars represent mean
CBF 6 SE for no. of animals indicated.
*P , 0.01, statistically signiﬁcant dif-
ference between stimulated and un-
stimulated sides (by paired t-test).
†P , 0.05, statistically signiﬁcantly
greater percentage of stimulation of
CBF in caffeine-treated rats than in
saline-treated control group (by
grouped t-test applied to logarithmic
transforms of the individual %differ-
ences between stimulated and un-
stimulated sides).
H825 ADJUSTMENT OF CEREBRAL BLOOD FLOW TO NEURONAL ACTIVITYulation of CBF, both caffeine-sensitive and NO-sensi-
tive, in which blockade of one might result in
compensation by the other, we examined the effects of
caffeine in combination with either 7-NI or L-NAME.
There were no additive effects of caffeine and either of
the NO synthase inhibitors. The results (Fig. 5) were
essentially the same as those seen with caffeine (Fig. 2)
or either of the NO synthase inhibitors (Fig. 4) alone.
DISCUSSION
Caffeine was recently found to attenuate in a dose-
dependent manner to the point of complete extinction
Fig. 4. Effects of 30 mg/kg N
G-nitro-L-
arginine methyl ester (L-NAME) ad-
ministered intravenously and of 30
mg/kg of 7-nitroindazole (7-NI) admin-
istered intraperitoneally on baseline
blood ﬂow and on functional activation
of blood ﬂow in four stations of the
whisker-to-barrel cortex pathway. A:
spinal trigeminal nucleus; B: principal
sensory trigeminal nucleus; C: ventral
posteromedial thalamic nucleus; D:
barrel ﬁeld of sensory cortex. Bar
heights and error bars represent
means 6 SE of no. of animals indi-
cated. See Statistics for statistical
tests. All side-to-side differences were
statistically signiﬁcant (P , 0.03); the
%values shown are the percentage of
differences between the two sides.
Also, baseline CBF (i.e., CBF on the
unstimulated side) was statistically
signiﬁcantly lower (P , 0.05) in all four
structures of the pathway in the rats
treated with L-NAME or 7-NI than in
the saline-treated control rats. *Statis-
tically signiﬁcantly lower percentage of
increase in blood ﬂow due to vibrissal
stimulation compared with that seen
in saline-treated (P , 0.05) or DMSO-
treated (P # 0.05) rats.
Fig. 5. Effects of combined administra-
tion of 20 mg/kg of caffeine adminis-
tered intravenously with either 30
mg/kg L-NAME administered intrave-
nously or 30 mg/kg 7-NI administered
intraperitoneally on baseline blood
ﬂow and on functional activation of
blood ﬂow in four stations of the whis-
ker-to-barrel cortex pathway. A: spinal
trigeminal nucleus; B: principal sen-
sory trigeminal nucleus; C: ventral
posteromedial thalamic nucleus; D:
barrel ﬁeld of sensory cortex. Bar
heights and error bars represent
means 6 SE of no. of animals indi-
cated. See Statistics for statistical
tests. All side-to-side differences were
statistically signiﬁcant (P , 0.03); the
percentage of values shown are the
means of the individual percentage of
differences between the two sides.
*P , 0.05, statistically signiﬁcant re-
duction in the percentage of increases
in blood ﬂow due to vibrissal stimula-
tion compared with those seen in nor-
mal saline-treated or DMSO-treated
control rats.
H826 ADJUSTMENT OF CEREBRAL BLOOD FLOW TO NEURONAL ACTIVITYthe marked increases in CBF that occur in insulin-
induced hypoglycemia, a condition in which levels of
adenosine and its metabolic degradation products are
greatly elevated in brain (11). Because adenosine is
known to have vasodilator actions, and caffeine is a
nonselective adenosine receptor antagonist, these ﬁnd-
ings suggested that adenosine was the mediator of the
enhancement of CBF in hypoglycemia. In the present
study, we have attempted to determine if it might also
mediate the increases in CBF associated with neuronal
functional activity. Previous studies suggesting a role
for adenosine in the functional activation of CBF were
based on changes in pial arterial diameters (15) or
laser-Doppler ﬂow patterns (7) induced in the sensory
cortex by topical applications of test agents to the
cortex of anesthetized animals. Because of reported
differences in the effects of NO synthase inhibitors on
functional activation of CBF in anesthetized and un-
anesthetized animals and in different stations of an
activated pathway (1, 2, 4, 7, 12, 19, 33, 36), in the
present study we measured absolute perfusion rates in
four stations of the whisker-to-barrel cortex pathways
under more physiological conditions, e.g., parenteral
administration of the test compounds to unanesthe-
tized animals.
The results indicate that caffeine-sensitive mecha-
nisms do contribute to the functional activation of CBF
in some but not all stations of the activated pathway.
Vibrissal stimulation markedly raised CBF in the four
stations examined, but caffeine statistically signiﬁ-
cantly reduced the percent enhancement only in the
spinal and principal sensory trigeminal nuclei and not
at all in the VPM thalamic nucleus and barrel cortex.
Even in the two structures in which it was effective,
however, it failed to abolish the increases in CBF. The
limited effects of caffeine cannot be explained by inad-
equate dosage. The 20 mg/kg dose had been sufﬁcient
to block completely the increases in CBF in insulin-
induced hypoglycemia (11) and appeared to exert close
to maximal effects in the present study inasmuch as
the 20 and 40 mg/kg doses had comparable effects on
both baseline CBF and the increases evoked by vibris-
sal stimulation. In fact, the higher dose of caffeine, if
anything, magniﬁed the stimulation-induced increase
in CBF in the barrel cortex where it also enhanced the
metabolic response to stimulation. Possibly increased
production of metabolic products with vasodilator ac-
tions might have overshadowed the inhibitory effects of
caffeine. This may explain why we observed no inhibi-
tion by caffeine in the barrel cortex in contrast to
previous studies in which topical application of theoph-
ylline or adenosine deaminase to the somatosensory
cortex reduced functional activation of CBF (7, 15).
Although caffeine failed to abolish the functional
activation of CBF in the brain stem nuclei, the reduc-
tions there were quite substantial. Many drugs sup-
press neuronal functions, and it was conceivable that
caffeine, acting on adenosine receptors on neurons or
on other cellular processes, might have reduced the
CBF responses by lowering the intensity of neuronal
functional activation rather than by inhibiting the ad-
justment of CBF to functional activity. This was appar-
ently not the case. Stimulation-dependent activation of
local glucose utilization is directly related to neuronal
spike activity (32), and vibrissal stimulation markedly
stimulated lCMRGlc in all four stations of the pathway,
particularly in the brain stem nuclei. Caffeine, how-
ever, altered neither baseline nor functionally acti-
vated levels of glucose utilization in the brain stem
nuclei, indicating that the attenuation of the CBF
responses there was not due to diminished neuronal
activation.
The methylxanthines, caffeine and theophylline, are
potent nonspeciﬁc inhibitors of adenosine receptors,
but they also have other actions, e.g., phosphodiester-
ase inhibition, calcium mobilization, benzodiazopine
receptor binding, etc. We chose caffeine because of its
lesser effects on baseline CBF and also because it is
less potent than theophylline with respect to some of
those other actions of the methyxanthines. The lower
dose of caffeine that we used, i.e., 20 mg/kg, has been
considered the upper limit before risking actions unre-
lated to adenosine receptor antagonism (9, 26), and our
higher dose, 40 mg/kg, did not reduce the functional
activation of CBF in the brain stem nuclei to any
greater degree. Therefore, it is likely that the effects of
caffeine we observed were maximal and predominantly
due to adenosine receptor antagonism.
The fact that caffeine maximally reduced CBF re-
sponses to functional activation by about one-half in
only two of the four stations of the pathway indicated
that other vasodilator mechanisms independent of
adenosine were involved. There are many endogenous
compounds in brain that can inﬂuence cerebral vascu-
lar tone, and one or more of them could be involved in
redundant mechanisms of CBF regulation during neu-
ronal functional activation. NO is one such candidate.
Several studies have reported that NO synthase inhi-
bition by drugs markedly reduce or eliminate the CBF
responses to vibrissal stimulation (6, 7, 12). Also, stud-
ies in which residual NO synthase activity was inhib-
ited with nitroarginine in mice lacking either the neu-
ronal or the endothelial NO synthase gene have
implicated NO derived from neuronal NO synthase as
the mediator (2, 19). Cholet et al. (4, 5) observed re-
gional differences in these effects; functional activation
of CBF in the trigeminal nuclei was unaffected by
neuronal NO synthase inhibition with 7-NI but was
totally eliminated in the VPM thalamic nucleus and
sensory cortex. Dirnagl and colleagues (7) examined
the effects of both adenosine receptor antagonists and
NO synthase inhibitors and concluded that both aden-
osine and NO were involved with interacting modes of
action. All of these studies were carried out in anesthe-
tized animals, sometimes with the NO synthase inhib-
itors applied topically to the cortex. There have been
contradictory reports on whether superfusion of the
cortex with the L-nitroarginine suppresses somatosen-
sory evoked potentials (17, 22, 23). If so, then attenu-
ation of functional activation of CBF by nitroarginine
so administered might reﬂect more suppression of neu-
ronal functional activation rather than the CBF re-
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however, that restoration of NO levels in the tissue by
NO donor agents after topical application of nitroargi-
nine restores the CBF response to vibrissal stimulation
(16). In all reported studies in which nitroarginine was
administered systemically or intrathecally to unanes-
thetized animals, no effects on the percent enhance-
ment of CBF elicited by vibrissal stimulation were
observed (1, 33, 36).
Therefore, to reexamine the role of NO in the CBF
responses to vibrissal stimulation in unanesthetized
rats, we included experiments on the effects of
L-NAME, a nonspeciﬁc inhibitor of all isoforms of NO
synthase, and 7-NI, a speciﬁc inhibitor of only the
neuronal isoform. These inhibitors were administered
alone or in combination with caffeine to determine if
the residual CBF responses in the trigeminal nuclei
after caffeine treatment were mediated by NO. The
intravenous administration of L-NAME raised MABP
and lowered baseline CBF, indicating effective inhibi-
tion of, at least, the endothelial NO synthase. 7-NI was
injected intraperitoneally 30 min before onset of vibris-
sal stimulation and measurement of CBF; this dose,
mode of administration, and timing had previously
been shown to inhibit brain NO synthase activity by
75–89% in various brain regions, including compo-
nents of the whisker-to-barrel cortex pathway (5, 20).
In our study, 7-NI did not affect blood pressure, prob-
ably because it inhibited only neuronal and not endo-
thelial NO synthase, but it did lower baseline CBF,
indicating tonic inﬂuence of neuronal NO synthase
activity on the cerebral circulation. Nevertheless, de-
spite the evidence that they had inhibited NO synthase
activity, neither inhibitor had any effect on the per-
centage of enhancements of CBF by vibrissal stimula-
tion in the two trigeminal nuclei. On the other hand,
both reduced the CBF response in the VPM thalamic
nucleus, and 7-NI had the same effect in the barrel
cortex as well. Therefore, the effects of 7-NI were
almost opposite to those of caffeine. Administration of
combinations of NO synthase inhibitors and caffeine
yielded results essentially like those obtained with
each of the drugs alone; there were no additive effects,
indicating that residual responses remaining after
blockade of adenosine receptors or NO formation were
not mediated by NO or adenosine, respectively.
Our results conﬁrm the ﬁndings of Cholet et al. (4, 5)
that inhibition of neuronal NO synthase activity with
7-NI suppresses CBF responses to vibrissal stimula-
tion in the VPM thalamic nucleus and barrel cortex but
not in the trigeminal nuclei. However, they did not
examine the effects of L-NAME. In our earlier studies
(1, 33), L-NAME did not statistically signiﬁcantly affect
the percent enhancement of CBF elicited by vibrissal
stimulation in any of the four structures of the whis-
ker-to-barrel cortex pathway, despite inhibitions of to-
tal brain NO synthase activity by .50% after systemic
and more than 80% after intracisternal administra-
tion. The effects of L-NAME in the present study were,
in general, similar. Despite evidence that it had inhib-
ited at least endothelial NO synthase activity (e.g.,
elevated arterial blood pressure and cerebral vascular
resistance), it had no signiﬁcant effects on the CBF
responses to stimulation in any of the four structures
except for the VPM nucleus. The reason for this differ-
ence is unclear, possibly a spurious statistical result in
one or the other study because of limited sample sizes.
The results obtained with 7-NI, however, suggest a role
for NO, at least in some regions of the brain. The
difference in the effects of L-NAME and 7-NI supports
a role for neuronal NO synthase and suggests that the
dose of L-NAME was sufﬁcient to inhibit only endothe-
lial and not neuronal NO synthase activities.
On the basis of our previous ﬁndings with L-NAME
(1, 33), we had concluded that, although NO exerted a
tonic vasodilator inﬂuence on the cerebral circulation,
it did not mediate the enhancement of CBF by sensory
stimulation. The results of the present study indicate,
however, that mechanisms sensitive either to caffeine
or to neuronal NO synthase inhibition may contribute,
but with opposite regional patterns of distribution
within the whisker-to-barrel cortex pathway. It may be
of signiﬁcance that the caffeine effects are conﬁned to
the trigeminal nuclei, the direct projection zones from
the peripheral sense organs that contain the primary
synapses of the pathway, and are absent in the thala-
mus and cortex where the secondary and higher-level
synapses reside, whereas NO produced by neuronal
NO synthase appears to operate in the regions contain-
ing the secondary and not primary synapses. In any
case, neither the caffeine-sensitive nor the NO-depen-
dent mechanisms, alone or in combination, account
fully for the functional activation of CBF in any region.
They may participate in but do not mediate the adjust-
ment of the CBF to functional activity, and other mech-
anisms must also be involved. Involvement of cycloox-
genase-2 in the enhancement of CBF in the sensory
cortex by vibrissal stimulation has been reported re-
cently (24). The nature of the participation of these
various mechanisms is unclear, but in the case of NO
recent evidence suggests that its role is permissive
(16). The complexity of multiple regulatory mecha-
nisms with different regional distributions presents a
formidable problem for future studies.
We are grateful to Dr. Charles Kennedy for helpful discussions
and suggestions.
These studies were supported in part by a grant from the National
Association for Research in Schizophrenia and Affective Disorders.
REFERENCES
1. Adachi K, Takahashi S, Melzer P, Campos KL, Nelson T,
Kennedy C, and Sokoloff L. Increases in local cerebral blood
ﬂow associated with somatosensory activation are not mediated
by NO. Am J Physiol Heart Circ Physiol 267: H2155–H2162,
1994.
2. Ayata C, Ma J, Meng W, Huang P, and Moskowitz MA.
L-NA-sensitive rCBF augmentation during vibrissal stimulation
in type III nitric oxide synthase mutant mice. J Cereb Blood Flow
Metab 16: 539–541, 1996.
3. Bryan RM, Hollinger BR, Keefer KA, and Rage RB. Re-
gional cerebral and neural lobe blood ﬂow during insulin-induced
hypoglycemia in unanesthetized rats. J Cereb Blood Flow Metab
7: 96–102, 1987.
H828 ADJUSTMENT OF CEREBRAL BLOOD FLOW TO NEURONAL ACTIVITY4. Cholet N, Bonvento G, and Seylaz J. Effect of neuronal NO
synthase inhibition on the cerebral vasodilatory response to
somatosensory stimulation. Brain Res 708: 197–200, 1996.
5. Cholet N, Seylaz J, Lacombe P, and Bonvento G. Local
uncoupling of the cerebrovascular and metabolic responses to
somatosensory stimulation after neuronal nitric oxide synthase
inhibition. J Cereb Blood Flow Metab 17: 1191–1201, 1997.
6. Dirnagl U, Lindauer U, and Villinger A. Role of nitric oxide
in the coupling of cerebral blood ﬂow to neural activation in rats.
Neurosci Lett 149: 43–46, 1993.
7. Dirnagl U, Niwa K, Lindauer U, and Villinger A. Coupling of
cerebral blood ﬂow to neural activation: role of adenosine and
nitric oxide. Am J Physiol Heart Circ Physiol 267: H296–H301,
1994.
8. Ginsberg MD, Dietrich WD, and Busto R. Coupled forebrain
increases of local cerebral glucose utilization and blood ﬂow
during physiologic stimulation of a somatosensory pathway in
the rat: demonstration by double label autoradiography. Neurol-
ogy 37: 11–19, 1987.
9. Hirsh K. Central nervous system pharmacology of the dietary
methylxanthines. In: The Methylxanthine Beverages and Foods:
Chemistry, Consumption, and Health Effects, edited by Spiller
GA. New York: Liss, 1984, p. 235–301.
10. Horinaka N, Artz N, Jehle J, Takahashi S, Kennedy C, and
Sokoloff L. Examination of potential mechanisms in the en-
hancement of cerebral blood ﬂow by hypoglycemia and pharma-
cological doses of deoxyglucose. J Cereb Blood Flow Metab 17:
54–63, 1997.
11. Horinaka N, Kuang TY, Pak H, Wang R, Jehle J, Kennedy
C, and Sokoloff L. Blockade of cerebral blood ﬂow response to
insulin-induced hypoglycemia by caffeine and glibenclamide in
conscious rats. J Cereb Blood Flow Metab 17: 1309–1318, 1997.
12. Irikura K, Maynard KI, and Moskowitz MA. Importance of
nitric oxide synthase inhibition to the attenuated vascular re-
sponses induced by topical L-nitroarginine during vibrissal stim-
ulation. J Cereb Blood Flow Metab 14: 45–48, 1994.
13. Kadekaro M, Crane AM, and Sokoloff L. Differential effects
of electrical stimulation of sciatic nerve on metabolic activity in
spinal cord and dorsal root ganglion in the rat. Proc Natl Acad
Sci USA 82: 6010–6013, 1985.
14. Kety SS and Schmidt CF. The effects of altered arterial ten-
sions of carbon dioxide and oxygen on cerebral blood ﬂow and
cerebral oxygen consumption of normal young men. J Clin Invest
27: 484–492, 1948.
15. Ko KR, Ngai AC, and Winn HR. Role of adenosine in regula-
tion of cerebral blood ﬂow in sensory cortex. Am J Physiol Heart
Circ Physiol 259: H1703–H1708, 1990.
16. Lindauer U, Megow D, Matsuda H, and Dirnagl U. Nitric
oxide: a modulator, but not a mediator, of neurovascular cou-
pling in rat somatosensory cortex. Am J Physiol Heart Circ
Physiol 277: H799–H811, 1999.
17. Lindauer U, Megow D, Schultze J, Weber JR, and Dirnagl
U. Nitric oxide synthase inhibition does not affect somatosensory
evoked potentials in the rat. Neurosci Lett 216: 207–210, 1996.
18. Lou HC, Edvinsson L, MacKenzie ET. The concept of cou-
pling blood ﬂow to brain function: revision required? Ann Neurol
22: 287–297, 1987.
19. Ma J, Ayata C, Huang PL, Fishman MC, and Moskowitz
MA. Regional cerebral blood ﬂow response to vibrissal stimula-
tion in mice lacking type I NOS gene expression. Am J Physiol
Heart Circ Physiol 270: H1085–H1090, 1996.
20. MacKenzie GM, Rose S, PA, Bland-Ward Moore PK, Jen-
ner P, Marsden CD. Time course of inhibition of brain nitric
oxide synthase by 7-nitroindazole. Neuroreport 5: 1993–1996,
1994.
21. Mata M, Fink DJ, Gainer H, Smith CB, Davidsen L, Savaki
H, Schwartz WJ, and Sokoloff L. Activity-dependent energy
metabolism in rat posterior pituitary primarily reﬂects sodium
pump activity. J Neurochem 34: 213–215, 1980.
22. Ngai AC, Meno JR, Jolley MA, and Winn HR. Suppression of
somatosensory evoked potentials by nitric oxide synthase inhi-
bition in rats; methodological differences. Neurosci Lett 245:
171–174, 1998.
23. Ngai AC, Meno JR, and Winn HR. L-NNA suppresses cere-
brovascular response and evoked potentials during somatosen-
sory stimulation. Am J Physiol Heart Circ Physiol 269: H1803–
H1810, 1995.
24. Niwa K, Araki E, Morham SG, Elizabeth Ross M, and
Iadecola C. Cyclooxygenase-2 contributes to functional hyper-
emia in whisker-barrel cortex. J Neurosci 20: 763–770, 2000.
25. Phillis JW. Adenosine in the control of the cerebral circulation.
Cerebrovasc Brain Metab Rev 1: 26–54, 1989.
26. Phyllis JW and DeLong RE. The role of adenosine in cerebral
vascular regulation during reductions in perfusion pressure.
J Pharm Pharmacol 38: 460–462, 1986.
27. Roy CS and Sherrington CS. On the regulation of the blood
supply of the brain. J Physiol (Lond) 11: 85–108, 1890.
28. Rubio R, Berne RM, and Winn HR. Production, metabolism
and possible functions of adenosine in brain tissue in situ. In:
Cerebral Vascular Smooth Muscle and Its Control, edited by
Purves MJ and Elliott K. Amsterdam: Elsevier, 1978, p. 355–
378.
29. Sakurada O, Kennedy C, Jehle J, Brown JD, Carbin GL,
and Sokoloff L. Measurement of local cerebral blood ﬂow with
iodo[
14C]antipyrine. Am J Physiol Heart Circ Physiol 234: H59–
H66, 1978.
30. Sokoloff L. Local cerebral energy metabolism: its relationships
to local functional activity and blood ﬂow. In: Cerebral Vascular
Smooth Muscle and Its Control, edited by Purves MJ and Elliott
K. Amsterdam: Elsevier, 1978, p. 171–197.
31. Sokoloff L. Localization of functional activity in the central
nervous system by measurement of glucose utilization with
radioactive deoxyglucose. J Cereb Blood Flow Metab 1: 7–36,
1981.
32. Sokoloff L. Energetics of functional activation in neural tissues.
Neurochem Res 24: 321–329, 1999.
33. Sokoloff L, Kennedy C, Adachi K, Wang F, Takahashi S,
and Melzer P. Effects of inhibitors of nitric oxide synthase on
resting local cerebral blood ﬂow and on the changes induced by
hypercapnia or local functional activity. In: Pharmacology of
Cerebral Ischemia 1992, edited by Krieglstein J and Oberpichler
H. Stuttgart, Germany: Wissenschaftliche, 1992, p. 371–382.
34. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak
CS, Pettigrew KD, Sakurada O, and Shinohara M. The
[
14C]deoxyglucose method for the measurement of local cerebral
glucose utilization: theory, procedure, and normal values in the
conscious and anesthetized albino rat. J Neurochem 28: 897–
916, 1977.
35. Takahashi S, Cook M, Jehle J, Kennedy C, and Sokoloff L.
Lack of effects of inhibition of nitric oxide synthesis on local
cerebral glucose utilization in the rat brain. J Neurochem 65:
414–419, 1995.
36. Wang Q, Kjaer T, Jorgensen MB, Paulson OB, and Lassen
NA. Nitric oxide does not act as a mediator coupling cerebral
blood ﬂow to neural activity following somatosensory stimuli in
rats. Neurol Res 15: 33–36, 1993.
37. Winn H, Rubio R, and Berne RM. The role of adenosine in the
regulation of cerebral blood ﬂow. J Cereb Blood Flow Metab 1:
239–244, 1981.
H829 ADJUSTMENT OF CEREBRAL BLOOD FLOW TO NEURONAL ACTIVITY